Profile picture

Professor Sanjay Kaul

Cedars-Sinai Medical Centre, Los Angeles (United States of America)
Follow
Logo ESC

Contributor content

The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes
Presentation
The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources